Observational Safety Study in Subjects Using Levemir (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus
Phase of Trial: Phase IV
Latest Information Update: 03 Nov 2016
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms LevSafeQD
- Sponsors Novo Nordisk
- 15 Jan 2010 Actual patient number (747) added as reported by ClinicalTrials.gov.
- 15 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jan 2010 Actual end date (October 2009) added as reported by ClinicalTrials.gov.